4
Changes in Ownership
C4 Therapeutics, Inc. Filed Acc 0001209191-21-056482
Director sold 81,676 shares at an average $48.78 ($3,984,396)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Prokupets Elena Director | 2021-09-14 | Sale | −492 | $50.01 | $24,603 | 83,522 | I |
| Prokupets Elena Director | 2021-09-14 | Sale | −492 | $50.03 | $24,614 | 587,731 | I |
| Prokupets Elena Director | 2021-09-15 | Sale | −30,000 | $48.71 | $1,461,204 | 53,522 | I |
| Prokupets Elena Director | 2021-09-15 | Sale | −24,193 | $48.97 | $1,184,690 | 563,538 | I |
| Prokupets Elena Director | 2021-09-16 | Sale | −346 | $50.01 | $17,303 | 53,176 | I |
| Prokupets Elena Director | 2021-09-16 | Sale | −25,807 | $48.62 | $1,254,677 | 510,731 | I |
| Prokupets Elena Director | 2021-09-16 | Sale | −346 | $50.01 | $17,305 | 510,385 | I |
| Open-market sales · 81,676 sh · avg $48.78 · $3,984,396 | |||||||
Loading xslF345X03/doc4.xml…